This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effectiveness and Costs of Enhanced Cocaine Treatments

This study has been completed.
Sponsor:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00167258
First received: September 9, 2005
Last updated: December 14, 2009
Last verified: December 2009
September 9, 2005
December 14, 2009
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00167258 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effectiveness and Costs of Enhanced Cocaine Treatments
Not Provided
The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Cocaine Dependence
  • Behavioral: Voucher Reinforcement
  • Behavioral: Extra Counseling Services
  • Behavioral: Voucher Reinforcement + Extra Counseling Services
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
February 2007
Not Provided

Inclusion Criteria:

  • Enrollment in an intensive outpatient program (IOP) for no more than 1 month
  • Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)
  • 18-65 years of age
  • Ability to provide names of informants to help locate subject for follow-up

Exclusion Criteria:

  • IV heroin use in last year
  • Acute medical/psychiatric diagnosis that precludes outpatient treatment
  • Inpatient treatment for 6 weeks or more prior to IOP treatment
  • Incarceration for 6 months or more prior to IOP treatment
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00167258
702110
Not Provided
Not Provided
Not Provided
Dr. James McKay, University of Pennsylvania
University of Pennsylvania
Not Provided
Principal Investigator: James R McKay, PhD University of Pennsylvania
University of Pennsylvania
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP